174 related articles for article (PubMed ID: 15650519)
1. Intraocular properties of urokinase-derived antiangiogenic A6 peptide in rabbits.
Koh HJ; Cheng L; Bessho K; Jones TR; Davidson MC; Freeman WR
J Ocul Pharmacol Ther; 2004 Oct; 20(5):439-49. PubMed ID: 15650519
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intraocular pharmacokinetics and toxicity of prinomastat (AG3340) in the rabbit.
Cheng L; Rivero ME; Garcia CR; McDermott CD; Keefe KS; Wiley CA; Soules KA; Bergeron-Lynn G; Vekich S; Zhang K; Appelt K; Freeman WR
J Ocul Pharmacol Ther; 2001 Jun; 17(3):295-304. PubMed ID: 11436949
[TBL] [Abstract][Full Text] [Related]
3. Intraocular properties of a repository urokinase receptor antagonist a36 Peptide in rabbits.
Falkenstein IA; Cheng L; Jones TR; Freeman WR; Babson B; Kozak I; Tammewar AM; Barron EC
Curr Eye Res; 2010 Aug; 35(8):742-50. PubMed ID: 20673051
[TBL] [Abstract][Full Text] [Related]
4. Effect of a novel octapeptide urokinase fragment, A6, on experimental choroidal neovascularization in the monkey.
Koh HJ; Freeman WR; Azen SP; Flaxel CJ; Labree LD; Cheng L; Wills M; Jones TR
Retina; 2006 Feb; 26(2):202-9. PubMed ID: 16467679
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment.
Unal M; Peyman GA
Retina; 2000; 20(1):69-75. PubMed ID: 10696751
[TBL] [Abstract][Full Text] [Related]
6. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.
Goldenberg DT; Giblin FJ; Cheng M; Chintala SK; Trese MT; Drenser KA; Ruby AJ
Retina; 2011 Feb; 31(2):393-400. PubMed ID: 21099453
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6.
Koh HJ; Bessho K; Cheng L; Bartsch DU; Jones TR; Bergeron-Lynn G; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):635-40. PubMed ID: 14744908
[TBL] [Abstract][Full Text] [Related]
8. Study of inhibitory effects of an antiangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in rats.
Bezerra Y; Fuselier JA; Peyman GA; Oner H; Drouant G; Coy DH
Retina; 2005; 25(3):345-54. PubMed ID: 15805913
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
[TBL] [Abstract][Full Text] [Related]
10. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
11. Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pig.
Tammewar AM; Cheng L; Hostetler KY; Falkenstein I; Beadle JR; Barron EC; Kozak I; Freeman WR
J Ocul Pharmacol Ther; 2007 Oct; 23(5):433-44. PubMed ID: 17900229
[TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.
Zhang Y; Bazzazi H; Lima E Silva R; Pandey NB; Green JJ; Campochiaro PA; Popel AS
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5266-5276. PubMed ID: 30383198
[TBL] [Abstract][Full Text] [Related]
13. Intraocular toxicity and pharmacokinetics of candesartan in a rabbit model.
Lee JE; Lim DW; Park HJ; Shin JH; Lee SM; Oum BS
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2924-9. PubMed ID: 21228384
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes.
Sakurai K; Akiyama H; Shimoda Y; Yoshida I; Kurabayashi M; Kishi S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4905-16. PubMed ID: 19407010
[TBL] [Abstract][Full Text] [Related]
15. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
Chen M; Li X; Liu J; Han Y; Cheng L
J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
[TBL] [Abstract][Full Text] [Related]
16. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.
Inan UU; Avci B; Kusbeci T; Kaderli B; Avci R; Temel SG
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1773-81. PubMed ID: 17389511
[TBL] [Abstract][Full Text] [Related]
17. Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model.
Park SJ; Oh J; Kim YK; Park JH; Park JY; Hong HK; Park KH; Lee JE; Kim HM; Chung JY; Woo SJ
Eye (Lond); 2015 Apr; 29(4):561-8. PubMed ID: 25592118
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal toxicity of garenoxacin.
Esfahani MR; Kazi AA; Peyman GA; Dellacroce JT; Aydin E
Retina; 2006 Feb; 26(2):182-6. PubMed ID: 16467675
[TBL] [Abstract][Full Text] [Related]
19. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
[TBL] [Abstract][Full Text] [Related]
20. Retinal toxicity of triamcinolone's vehicle (benzyl alcohol): an electrophysiologic and electron microscopic study.
Macky TA; Helmy D; El Shazly N
Graefes Arch Clin Exp Ophthalmol; 2007 Jun; 245(6):817-24. PubMed ID: 17111149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
